Abstract
Mucociliary clearance (MC) is an important defense mechanism of the respiratory system to eliminate inhaled and possibly noxious particles from the lung. Although the principal mechanics of MC seem to be relatively clear there are still open questions regarding the long-term clearance of particles. Therefore, we have developed a new set-up based on embryonic chicken trachea (ECT) to investigate mucociliary particle clearance in more detail. ECT was placed in an incubation chamber after carbon particles were applied and tracked using optical microscopy. The aim of the study was to validate this model by investigating the impact of temperature, humidity and drugs on particle transport rates. Particles were transported reproducibly along the trachea and clearance velocity (2.39 ± 0.25) mm/min was found to be in accordance to data reported in literature. Variation in temperature resulted in significantly reduced MC: (0.40 ± 0.12) mm/min (20 °C); (0.42 ± 0.10) mm/min (45 °C). Decreasing humidity (99–60%) had no significant effect on MC, whereas reduction to 20% humidity showed a significant influence on particle clearance. The use of different cilio- and muco-active drugs (Propranolol, Terbutalin, N-acetylcysteine) resulted in altered MC according to the pharmacological effect of the substances: a concentration dependent decrease of MC was found for Propranolol. From our results we conclude that this model can be employed to investigate MC of particles in more detail. Hence, the model may help to understand and identify decisive physico-chemical parameters for MC and to answer open questions regarding the long-term clearance phenomenon.
Similar content being viewed by others
References
K. Corkery. Inhalable drugs for systemic therapy. Resp. Care 45(7):831–835 (2000).
G. Oberdörster, E. Oberdörster, and J. Oberdörster. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Persp. 113(7):823–839 (2005).
D. A. Groneberg, C. Witt, U. Wagner, K. F. Chung, and A. Fischer. Fundamentals of pulmonary drug delivery. Resp. Med. 97(4):382–387 (2003).
P. Brand, C. Rieger, T. Beinert, and J. Heyder. Aerosol derived airway morphometry in healthy subjects. Eur. Resp. J. 8(10):1639–1646 (1995).
G. Scheuch, J. Gebhart, G. Heigwer, and W. Stahlhofen. New device for human inhalation studies with small aerosol boluses. J. Aerosol Sci. 20(8):1293–1296 (1989).
W. Möller, K. Häußinger, R. Winkler-Heil, et al. Mucociliary and long-term particle clearance in the airways of healthy nonsmoker subjects. J. Appl. Physiol. 97(6):2200–2206 (2004).
E. Marttin, N. G. M. Schipper, J. Coos Verhoef, and F. W. H. M. Merkus. Nasal mucociliary clearance as a factor in nasal drug delivery. Adv. Drug Deliv. Rev. 29(1–2):13–38 (1998).
M. Fuloria, and B. K. Rubin. Evaluating the efficacy of mucoactive aerosol therapy. Resp. Care 45(7):868–873 (2000).
H. Matsui, S. H. Randell, S. W. Peretti, C. W. Davis, and R. C. Boucher. Coordinated clearance of periciliary liquid and mucus from airway surfaces. J. Clin. Invest. 102(6):1125–1131 (1998).
P. Verdugo. Goblet cells secretion and mucogenesis. Ann. Rev. Physiol. 52:157–176 (1990).
M. I. Lethem. The role of tracheobronchial mucus in drug administration to the airways. Adv. Drug Deliv. Rev. 11(3):271–298 (1993).
E. P. Lillehoj, and K. C. Kim. Airway mucus: its components and function. Arch. Pharm. Res. 25(6):770–780 (2002).
T. Gray, J. S. Koo, and P. Nettesheim. Regulation of mucous differentiation and mucin gene expression in the tracheobronchial epithelium. Toxicol. 160(1–3):35–46 (2001).
S. Kirkham, J. K. Sheehan, D. Knight, P. S. Richardson, and D. J. Thornton. Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B. Biochem. J. 361(3):537–546 (2002).
D. A. Groneberg, P. R. Eynott, S. Lim, et al. Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology 40(4):367–373 (2002).
D. A. Groneberg, P. R. Eynott, T. Oates, et al. Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Resp. Med. 96(2):81–86 (2002).
J. R. Blake, and M. A. Sleigh. Mechanics of ciliary locomotion. Biol. Rev. Cambr. Phil. Soc. 49(1):85–125 (1974).
P. Satir, and S. T. Christensen. Overview of structure and function of mammalian cilia. Ann. Rev. Physiol. 69:377–400 (2007).
B. A. Afzelius. Ciliary structure in health and disease. Acta Oto-Rhino-Laryngol. Bel. 54(3):287–291 (2000).
M. A. Sleigh, J. R. Blake, and N. Liron. The propulsion of mucus by cilia. Am. Rev. Resp. Dis. 137(3):726–741 (1988).
G. Scheuch, and W. Stahlhofen. Particle deposition of inhaled aerosol boluses in the upper human airways. J. Aerosol. Sci. 18(6):725–727 (1987).
W. Stahlhofen, J. Gebhart, G. Rudolf, G. Scheuch, and K. Philipson. Clearance from the human airways of particles of different sizes deposited from inhaled aerosol boli. In Aerosols: Formation and Reactivity, Pergamon Press, Oxford, UK 1986.
W. Stahlhofen, R. Koebrich, G. Rudolf, and G. Scheuch. Short-term and long-term clearance of particles from the upper human respiratory tract as function of particle size. J. Aerosol. Sci. 21(Supp 1):407–410 (1990).
W. G. Kreyling, M. Semmler-Behnke, and W. Möller. Ultrafine particle–lung interactions: does size matter? J. Aerosol. Med. 19(1):74–83 (2006).
F. Dominici, R. D. Peng, M. L. Bell, et al. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. J. Am. Med. Assoc. 295(10):1127–1134 (2006).
I. Annesi-Maesano, F. Forastiere, N. Kunzli, and B. Brunekref. Particulate matter, science and EU policy. Eur. Resp. J. 29(3):428–431 (2007).
P. Gehr, M. Geiser, V. I. Hof, S. Schurch, U. Waber, and M. Baumann. Surfactant and inhaled particles in the conducting airways: structural, stereological, and biophysical aspects. Micros. Res. Techniq. 26(5):423–436 (1993).
P. Gehr, F. H. Y. Green, M. Geiser, V. Im Hof, M. M. Lee, and S. Schürch. Airway surfactant, a primary defense barrier: mechanical and immunological aspects. J. Aerosol. Med. 9(2):163–181 (1996).
M. Geiser, P. Gerber, I. Maye, V. Im Hof, and P. Gehr. Retention of Teflon particles in hamster lungs: a stereological study. J. Aerosol. Med. 13(1):43–55 (2000).
S. Schurch, P. Gehr, V. Im Hof, M. Geiser, and F. Green. Surfactant displaces particles toward the epithelium in airways and alveoli. Resp. Physiol. 80(1):17–32 (1990).
A. Peters, B. Veronesi, L. Calderon-Garciduenas, et al. Translocation and potential neurological effects of fine and ultrafine particles a critical update. Part. Fibre Toxicol. 3:13 (2006).
J. Iravani, and A. van As. Mucus transport in the tracheobronchial tree of normal and bronchitic rats. J. Pathol. 106(2):81–93 (1972).
H. J. M. Van De Donk, J. Zuidema, and F. W. H. M. Merkus. Correlation between the sensitivity of the ciliary beat frequency of human adenoid tissue and chicken embryo tracheas for some drugs. Rhinology 20(2):81–87 (1982).
W. M. Boek, S. G. Romeijn, K. Graamans, J. C. Verhoef, F. W. H. M. Merkus, and E. H. Huizing. Validation of animal experiments on ciliary function in vitro. I. The influence of substances used clinically. Acta Oto-Laryngol. 119(1):93–97 (1999).
W. M. Boek, S. G. Romeijn, K. Graamans, J. C. Verhoef, F. W. H. M. Merkus, and E. H. Huizing. Validation of animal experiments on ciliary function in vitro. II. The influence of absorption enhancers, preservatives and physiologic saline. Acta Oto-Laryngol. 119(1):98–101 (1999).
P. Merkus, S. G. Romeijn, J. Coos Verhoef, F. W. H. M. Merkus, and P. F. Schouwenburg. Classification of cilio-inhibiting effects of nasal drugs. Laryngoscope. 111(4I):595–602 (2001).
M. Sakagami. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv. Drug Deliv. Rev. 58(9–10):1030–1060 (2006).
E. B. M. B. Prophet, J. B. Arrington, and L. H. Sobin (eds.). Laboratory Methods in Histotechnology, American Registry of Pathology: Armed Forces Insitute of Pathology, Washington (DC), 1994.
P. Gehr, M. Bachofen, and E. R. Weibel. The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Resp. Physiol. 32(2):121–140 (1978).
V. Gerber, P. Gehr, R. Straub, M. Frenz, M. King, and V. Im Hof. Mucus quality on horse tracheal epithelium: microscopic grading based on transparency. Resp. Physiol. 107(1):67–74 (1997).
C. F. Clary-Meinesz, J. Cosson, P. Huitorel, and B. Blaive. Temperature effect on the ciliary beat frequency of human nasal and tracheal ciliated cells. Biol. Cell. 76(3):335–338 (1992).
A. J. Shah, and M. D. Donovan. Formulating gels for decreased mucociliary transport using rheologic properties: polyacrylic acids. AAPS PharmSciTech. 8(2) (2007).
B. K. Rubin. Immotile cilia syndrome (primary ciliary dyskinesia) and inflammatory lung disease. Clin. Chest Med. 9(4):657–668 (1988).
M. King. Relationship between mucus viscoelasticity and ciliary transport in guaran gel/frog palate model system. Biorheology. 17(3):249–254 (1980).
M. King. Interrelation between mechanical properties of mucus and mucociliary transport: effect of pharmacologic interventions. Biorheology 16(1–2):57–68 (1979).
S. A. Felicetti, R. K. Wolff, and B. A. Muggenburg. Comparison of tracheal mucous transport in rats, guinea pigs, rabbits, and dogs. J. Appl. Physiol. Resp. Environ. Exercise Physiol. 51(6):1612–1617 (1981).
W. Hofmann, and B. Asgharian. The effect of lung structure on mucociliary clearance and particle retention in human and rat lungs. Toxicol. Sci. 73(2):448–456 (2003).
W. M. Foster, E. Langenback, and E. H. Bergofsky. Measurement of tracheal and bronchial mucus velocities in man: relation to lung clearance. J. Appl. Physiol. Resp. Environ. Exercise Physiol. 48(6):965–971 (1980).
M. Salathe. Effects of ß-agonists on airway epithelial cells. J. Allergy Clin. Immun. 110(6):S275–S281 (2002).
M. King. Experimental models for studying mucociliary clearance. Eur. Resp. J. 11(1):222–228 (1998).
Acknowledgements
Leon Muijs and Beat Haenni are thanked for technical support and introduction to SEM/TEM imaging. Gregor Jung and Babette Hinkeldey are thanked for cover slip modification for the incubation chamber.
Financial support from the Federal German Ministry of Education and Research is gratefully acknowledged (Nano-Inhale-13N8890).
Author information
Authors and Affiliations
Corresponding author
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Video 1
Exemplary video for mucociliary clearance of carbon particles. Particles are clearly and reproducibly transported on the tracheal tissue. Particle clearance is unidirectional and always to the proximal end of the trachea. Visualization and tracking of the carbon particles was realized by transition light microscopy. (×100, top view; MPG 2.78 MB)
Rights and permissions
About this article
Cite this article
Henning, A., Schneider, M., Bur, M. et al. Embryonic Chicken Trachea as a New In Vitro Model for the Investigation of Mucociliary Particle Clearance in the Airways. AAPS PharmSciTech 9, 521–527 (2008). https://doi.org/10.1208/s12249-008-9072-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-008-9072-6